| Medications for Scleroderma, Arthritis, Autoimmune and Rheumatic Diseases |
| This page was written by Shelley Ensz, and has not yet been medically edited. See Disclaimer. |
| IVIg (Intravenous Immunoglobulin) |
| IVIg (Intravenous Immunoglobulin) is a blood product extracted from the plasma of about 20,000 blood donors. It contains the pooled human immunoglobulin Type G (IgG) which are antibodies of the immune system. IVIg is used to treat immune deficiencies and autoimmune and inflammtory diseases. |
| The plasma that the immunoglobulins come from has been vigorously screened, tested and found to be safe and free of HIV infection and the hepatitis virus. |
| An IVIg treatment can take 2- 5 days, several hours a day. Its effect last between 2 weeks to 3 months. |
| Clinical Trials: Completed, Positive Results ISN. |
| Newly refined antibody therapy may be potent treatment for autoimmune diseases. An old, fickle therapy for a variety of autoimmune diseases is getting a makeover, thanks to a decade-long investigation by Rockefeller University researchers. NewsWire. 04/25/09. |
| Home Intravenous Immunoglobulin Therapy Safe in Patients With Neuroimmunological Disorders. Intravenous (IV) immunoglobulin therapy has a favourable safety profile for patients with neuroimmunological disorders such as Guillain-Barré Syndrome, chronic inflammatory demyelinating polyneuropathy, myasthaenia gravis, polymyositis, dermatomyositis, and multifocal motor neuropathy. Doctor's Guide Channel. 04/18/08. (Also see: Guillain-Barré Syndrome, and Dermatomyositis/Polymyositis) |
| Doctor offers medical answers (about IVIg). Jennifer L. Holter, M.D., assistant professor of hematology/oncology and assistant director of the blood and marrow transplant program at the University of Oklahoma Medical Center, answered these questions regarding compromised immune systems and intravenous gamma-globulin (IVIg) treatment. NewsOK.com. 04/15/08. |
| Scleroderma Treatments and Clinical Trials ISN. |
| Go to Medications | ||||||||||||
|
||||||||||||